Total Payments
$5,196
2024 Payments
$957.86
Companies
16
Transactions
105
Medicare Patients
12,448
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$2,981 (57.4%)
Travel$2,119 (40.8%)
Other$95.61 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,981 | 93 | 57.4% |
| Travel and Lodging | $2,119 | 10 | 40.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95.61 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,971 | 60 | $0 (2024) |
| Boston Scientific Corporation | $664.09 | 11 | $0 (2024) |
| Medtronic, Inc. | $442.08 | 6 | $0 (2023) |
| Relievant Medsystems, Inc. | $354.80 | 3 | $0 (2023) |
| ABBVIE INC. | $193.87 | 9 | $0 (2024) |
| Saluda Medical Americas, Inc. | $193.22 | 1 | $0 (2023) |
| Nevro Corp. | $98.47 | 2 | $0 (2023) |
| Vertos Medical, Inc. | $89.71 | 3 | $0 (2023) |
| SPR Therapeutics, Inc | $37.33 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $36.89 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $957.86 | 25 | Boston Scientific Corporation ($664.09) |
| 2023 | $1,257 | 26 | Abbott Laboratories ($458.26) |
| 2022 | $2,359 | 40 | Abbott Laboratories ($2,250) |
| 2021 | $621.52 | 14 | Medtronic, Inc. ($410.91) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.19 | General |
| 11/01/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: INSTRUMENTS | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Neuromodulation | ||||||
| 09/19/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $10.83 | General |
| Category: Pain management | ||||||
| 08/30/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Neuromodulation | ||||||
| 07/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $51.76 | General |
| Category: Neuromodulation | ||||||
| 07/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 06/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Neuromodulation | ||||||
| 04/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $9.56 | General |
| Category: Pain | ||||||
| 03/14/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Neuromodulation | ||||||
| 02/19/2024 | Boston Scientific Corporation | Intracept (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $61.69 | General |
| Category: Pain | ||||||
| 02/19/2024 | Boston Scientific Corporation | Intracept (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $33.92 | General |
| Category: Pain | ||||||
| 02/09/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Pain | ||||||
| 02/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Neuromodulation | ||||||
| 01/27/2024 | Boston Scientific Corporation | Intracept (Device) | Travel and Lodging | Cash or cash equivalent | $198.81 | General |
| Category: Pain | ||||||
| 01/27/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $129.59 | General |
| Category: Pain | ||||||
| 01/27/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| Category: Pain | ||||||
| 01/27/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Pain | ||||||
| 01/27/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Pain | ||||||
| 01/26/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $61.54 | General |
| Category: Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 4,308 | 13,861 | $2.1M | $650,383 |
| 2022 | 33 | 5,036 | 11,727 | $1.9M | $600,016 |
| 2021 | 24 | 3,104 | 4,415 | $828,293 | $313,630 |
Total Patients
12,448
Total Services
30,003
Medicare Billing
$1.6M
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 148 | 175 | $203,700 | $76,934 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 659 | 910 | $182,000 | $75,038 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 703 | 1,031 | $154,650 | $59,975 | 38.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 205 | 1,090 | $86,110 | $49,506 | 57.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 142 | 167 | $128,000 | $41,895 | 32.7% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 16 | 32 | $112,000 | $38,756 | 34.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 120 | 186 | $147,000 | $35,921 | 24.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 119 | 198 | $225,000 | $34,181 | 15.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 148 | 716 | $50,120 | $24,615 | 49.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 97 | 147 | $73,500 | $23,646 | 32.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 104 | 169 | $87,150 | $22,324 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 212 | 212 | $63,600 | $22,255 | 35.0% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 77 | 77 | $30,800 | $18,632 | 60.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 114 | 191 | $126,700 | $17,864 | 14.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 57 | 92 | $46,000 | $13,624 | 29.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 84 | 175 | $35,000 | $13,178 | 37.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 20 | 24 | $31,450 | $9,603 | 30.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 158 | 161 | $12,880 | $9,578 | 74.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 56 | 58 | $14,500 | $8,901 | 61.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 78 | 170 | $27,360 | $8,852 | 32.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 71 | 106 | $26,500 | $8,406 | 31.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 23 | 36 | $34,650 | $6,355 | 18.3% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 19 | 23 | $15,600 | $5,374 | 34.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 186 | 1,046 | $15,690 | $5,245 | 33.4% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 11 | 22 | $77,000 | $5,093 | 6.6% |
About Dr. Christopher Anderson, M.D
Dr. Christopher Anderson, M.D is a Pain Medicine healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2016. The National Provider Identifier (NPI) number assigned to this provider is 1992159040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Anderson, M.D has received a total of $5,196 in payments from pharmaceutical and medical device companies, with $957.86 received in 2024. These payments were reported across 105 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,981).
As a Medicare-enrolled provider, Anderson has provided services to 12,448 Medicare beneficiaries, totaling 30,003 services with total Medicare billing of $1.6M. Data is available for 3 years (2021–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Elizabethtown, KY
- Active Since 04/14/2016
- Last Updated 06/09/2022
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1992159040
Products in Payments
- PROCLAIM (Device) $1,956
- Intracept (Device) $999.24
- AXIUM (Device) $779.32
- RESTORE (Device) $392.04
- Evoke SCS (Device) $193.22
- Senza (Device) $98.47
- BOTOX (Biological) $91.94
- mild Device Kit (Device) $89.71
- Proclaim IPG (Device) $79.13
- UBRELVY (Drug) $76.24
- OCTRODE (Device) $62.05
- PENTA (Device) $53.59
- SPRINT PNS System (Device) $37.33
- RELISTOR (Drug) $36.89
- INTELLIS ADAPTIVESTIM (Device) $31.17
- Aimovig (Biological) $30.19
- QULIPTA (Drug) $25.69
- HA MINUTEMAN G3-R (Device) $21.45
- Prodigy Family of SCS IPGs (Device) $21.06
- Penta SCS Leads (Device) $19.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.